IEQ Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72M | Buy |
572,973
+35,956
| +7% | +$4.52M | 0.44% | 32 |
|
|
2025
Q1 | $59.4M | Sell |
537,017
-20,887
| -4% | -$2.31M | 0.47% | 32 |
|
|
2024
Q4 | $76.2M | Buy |
557,904
+45,424
| +9% | +$6.2M | 0.74% | 22 |
|
|
2024
Q3 | $59M | Buy |
512,480
+6,394
| +1% | +$737K | 0.72% | 26 |
|
|
2024
Q2 | $69.7M | Sell |
506,086
-27
| -0% | -$3.72K | 0.94% | 19 |
|
|
2024
Q1 | $69.8M | Buy |
506,113
+23,287
| +5% | +$3.21M | 1% | 19 |
|
|
2023
Q4 | $63.6M | Buy |
482,826
+1,528
| +0.3% | +$201K | 1.06% | 18 |
|
|
2023
Q3 | $54.1M | Buy |
481,298
+30
| +0% | +$3.38K | 1.1% | 17 |
|
|
2023
Q2 | $45.4M | Buy |
+481,268
| New | +$45.4M | 0.92% | 20 |
|